Curanex Pharmaceuticals Q1 EPS $(0.11) Down From $(0.01) YoY
Benzinga Newsdesk 5 months ago
EarningsNews
Curanex Pharmaceuticals (NASDAQ:CURX) reported quarterly losses of $(0.11) per share. This is a 1000 percent decrease over losses of $(0.01) per share from the same period last year.
Curanex Pharmaceuticals (NASDAQ:CURX) reported quarterly losses of $(0.11) per share. This is a 1000 percent decrease over losses of $(0.01) per share from the same period last year.